condition The risk for ovarian cancer and skin cancer is increased with basal cell nevus syndrome, a rare genetic disorder. b

The risk for ovarian cancer and skin cancer is increased with basal cell nevus syndrome, a rare genetic disorder.

Basal Cell Nevus Syndrome (Gorlin Syndrome)

The risk for childhood brain tumor, ovarian tumors, and skin cancer is increased with basal cell nevus syndrome (also called Gorlin syndrome or nevoid basal cell carcinoma). This is a rare autosomal dominant cancer genetic syndrome. Features linked to basal cell nevus syndrome may include:

  • Development of more than 2 basal cell carcinomas (cancer of the outer layer of the skin) before age 20

  • Cysts in the jaw

  • Characteristic facial appearance

  • Calcification of the falx (a variation in the appearance of the skull that can be seen on X-rays)

  • Pits in the palms of the hands and soles of the feet

  • Macrocephaly (enlarged head size) 

  • Rib or vertebral abnormalities

  • Increased risk of medulloblastoma (cancerous or malignant brain tumor) during childhood

  • Increased risk of cardiac or ovarian fibromas (noncancer or benign tumors)

Basal cell nevus syndrome is caused by changes in a tumor suppressor gene called PTCH1. It is located on chromosome 9 or the SUFU mutation gene.

Molecular genetic testing of PTCH1 or SUFU is available on a clinical basis. 

Tumor suppressor genes often control cell growth and cell death. Every person is born with two copies of each tumor suppressor gene. One is inherited from the mother and one from the father. Both copies of a tumor suppressor gene must be changed (mutated) before a person may develop cancer. With basal cell nevus syndrome, the first mutation is inherited from either the mother or the father. This happens in 70% to 80% of cases. In 20% to 30% of cases, the first mutation is not inherited. It happens for the first time in the affected person. Whether inherited or not, this first mutation is present in all of the cells of the body from conception. It is called a germline mutation.

Whether a person who has a germline mutation will develop cancer and where the cancer will develop depends on where (which cell type) the second mutation happens. For instance, if the second mutation is in the skin, then skin cancer may develop. If it's in the ovary, then ovarian cancer may develop. The process of tumor development actually needs mutations in multiple growth control genes. Loss of both copies of PTCH1 is just the first step in the process. Experts don't know what causes these additional mutations. Possible causes include chemical, physical, or biological environmental exposures (such as sunlight). Or there may be chance errors when cells copy themselves.

Some people who have inherited a germline tumor suppressor gene mutation may never have cancer. This is because they never get the second mutation needed to knock out the function of the gene and start the process of tumor formation. This can make the cancer seem to skip generations in a family. But the mutation is still there. People with a PTCH1 mutation may or may not have cancer. But they always have a 50% chance of passing the mutation on to each of their children.

It's also important to remember that the gene responsible for basal cell nevus syndrome is not found on the sex chromosomes. So mutations can be inherited from the mother's side or the father's side of the family.

If you have a family history of cancers, discuss this with your healthcare provider. Ask if you should be screened for a familial cancer syndrome. Also ask if you should be screened for the development of certain tumors.

News & Publications

Quantity and Characteristics of Waste at a Level I Trauma Center

The purpose of this study was to quantify and describe the amount of waste generated by an Emergency Department, identify deviations from waste policy and explore areas for waste reduction.

The Climate-Smart Emergency Department: A Primer

Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.

Research Institute Blog

News and notes from the largest hospital-based research program in the United States


A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care